MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 24.02.2026
Merck & Co. Langfristiger Schuldenstrom 2011-2026 | MRK
Langfristiger Schuldenstrom Jährlich Merck & Co.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 294 M | 282 M | 285 M | 281 M | 304 M | 300 M | 236 M | - | 3 B | 300 M | 2.3 B | 1 B | 2.1 B | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3 B | 236 M | 890 M |
Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
3.63 M | - | 2.43 % | $ 254 M |  Germany |
 |
AbCellera Biologics
ABCL
|
5.82 M | $ 3.55 | -0.42 % | $ 1.06 B |  Canada |
 |
Acorda Therapeutics
ACOR
|
1.59 M | - | -24.86 % | $ 820 K |  USA |
 |
Acasti Pharma
ACST
|
75 K | - | 4.01 % | $ 150 M | Canada |
 |
Advaxis
ADXS
|
166 K | - | -9.65 % | $ 45.9 M | USA |
 |
AC Immune SA
ACIU
|
1.03 M | $ 3.25 | 3.83 % | $ 229 M |  Schweiz |
 |
I-Mab
IMAB
|
8.06 M | - | - | $ 866 M |  China |
 |
Aeglea BioTherapeutics
AGLE
|
625 K | - | - | $ 1.01 B | USA |
 |
AgeX Therapeutics
AGE
|
428 K | - | -10.17 % | $ 12.2 K | USA |
 |
Albireo Pharma
ALBO
|
3.08 M | - | -0.23 % | $ 916 M | USA |
 |
Aileron Therapeutics
ALRN
|
48 K | - | 10.36 % | $ 9.8 M | USA |
 |
Aptorum Group Limited
APM
|
433 K | $ 0.79 | 0.04 % | $ 4.31 M | China |
 |
ADC Therapeutics SA
ADCT
|
1.1 M | $ 4.12 | -1.9 % | $ 105 M | Schweiz |
 |
Arcturus Therapeutics Holdings
ARCT
|
4.21 M | $ 6.52 | -1.66 % | $ 179 M |  Israel |
 |
argenx SE
ARGX
|
6.53 M | $ 709.0 | 0.81 % | $ 25 B |  Niderland |
 |
Adverum Biotechnologies
ADVM
|
5.67 M | - | - | $ 86.2 M | USA |
 |
Ascendis Pharma A/S
ASND
|
14.2 M | $ 229.5 | -0.66 % | $ 5 B |  Danmark |
 |
Applied Genetic Technologies Corporation
AGTC
|
1.27 M | - | - | $ 26.5 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
57.6 K | $ 3.43 | -4.99 % | $ 8.25 B |  Australia |
 |
Applied Molecular Transport
AMTI
|
4.64 M | - | - | $ 10.1 M | USA |
 |
Atea Pharmaceuticals
AVIR
|
843 K | $ 6.08 | 0.41 % | $ 495 M | USA |
 |
Athersys
ATHX
|
1.01 M | - | 3.77 % | $ 22.4 M | USA |
 |
Akouos
AKUS
|
671 K | - | 0.23 % | $ 488 M | USA |
 |
Acer Therapeutics
ACER
|
104 K | - | 2.71 % | $ 14 M | USA |
 |
ARCA biopharma
ABIO
|
213 K | - | 1052.0 % | $ 415 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
317 K | - | 3.16 % | $ 1.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
271 K | - | 5.93 % | $ 314 M | Canada |
 |
AlloVir
ALVR
|
10.8 M | - | 4.14 % | $ 49.1 M | USA |
 |
Anika Therapeutics
ANIK
|
1.6 M | $ 14.54 | 1.25 % | $ 213 M | USA |
 |
Aptinyx
APTX
|
337 K | - | -39.0 % | $ 4.57 M | USA |
 |
BioCardia
BCDA
|
333 K | $ 1.3 | 2.36 % | $ 27.5 M | USA |
 |
Aptose Biosciences
APTO
|
428 K | - | -45.71 % | $ 1.2 M | Canada |
 |
AVEO Pharmaceuticals
AVEO
|
11 K | - | - | $ 521 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
419 K | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
137 K | $ 2.59 | -1.79 % | $ 16.3 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
5.05 M | $ 1.51 | -0.33 % | $ 385 M |  Britain |
 |
Athira Pharma
ATHA
|
414 K | - | - | $ 269 M | USA |
 |
BioNTech SE
BNTX
|
45 M | $ 94.8 | 4.71 % | $ 27.2 B | Germany |
 |
CureVac N.V.
CVAC
|
3.47 M | - | - | $ 867 M | Germany |
 |
Aravive
ARAV
|
2.2 M | - | -13.39 % | $ 1.45 M | USA |
 |
AstraZeneca PLC
AZN
|
382 M | - | - | $ 96.9 B | Britain |
 |
Actinium Pharmaceuticals
ATNM
|
569 K | $ 1.15 | 3.6 % | $ 34.6 M | USA |